Attached files

file filename
8-K - 8-K - iSatori, Inc.ifit8k050815.htm

Exhibit 99.1



[exhibit991001.jpg]



FOR IMMEDIATE RELEASE


iSatori Reports First Quarter 2015 Financial Results and Recent Developments

6% Increase in Net Revenues; Returns to Profitability



GOLDEN, CO--(MarketWired – May 8, 2015) - iSatori, Inc. (OTCQB: IFIT), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, under the iSatori (www.isatori.com), BioGenetic Laboratories (www.BioGeneticLabs.com), and Energize (www.TryEnergize.com) brands, today announced its first quarter 2015 results. A complete report of the Company's (GAAP) financial results for the first quarter ended March 31, 2015, will be available today on its quarterly report filed with the Securities and Exchange Commission on Form 10-Q.


iSatori's product revenues (net of returns and discounts) increased $179,000 or 6% to $3,398,000 for the three months ended March 31, 2015, compared to $3,219,000 for the same period in 2014. Gross product revenues increased 6% to $3,933,000 compared to $3,730,000 for the same period in 2014.  The increase in revenues can be attributed to increasing demand for their category-creating Bio-Gro™ product and newly released products which were not available during the three-month period ended March 31, 2014, such as Pre-Gro™ and Hyper-Gro™ (both of which are fortified with Bio-Gro™). Adjustments from revenues (for retailer advertising discounts, returns, promotional credits, and coupons) increased $24,000 or 5% to $535,000 for the three months ended March 31, 2015, compared to $511,000 for the same period in the previous year period. Total operating expenses decreased by $70,000 or -4% for first three months ended March 31, 2015, to $1,593,000 from $1,663,000 for the same period prior year. As a result, net income for the first quarter was $26,000 compared to net income of $336,000 or $.03 per share for the same period in 2014.


“We are pleased to announce our return to profitability. Our Company took very important steps during the last 120 days to streamline our business, eliminate poorly performing products, and increase customer demand for our products at retail,” said Stephen Adelé.  "As a result, we have been able to generate a positive year over year increase in revenues and bring our company back to profitability. Management remains confident in our ability to continue to drive increased shareholder value by executing our strategic growth objectives throughout the remainder of the year.”


First Quarter 2015 Highlights:


Ÿ

On January 5, 2015, the Company launched two new products fortified with clinically tested Bio-Gro™ Bio-Active Peptides to complement its growing GRO product line within in sports nutrition assortment. Pre-Gro™ is a pre-workout powder designed to deliver a high energy, muscle-building workout experience. Hyper-Gro™ is a lean muscle mass gainer shake mix that contains an exclusive 5-Phase Instantized Protein Blend with beef protein isolate as its number one source. Distribution for both products was secured for the Company’s primary channels, such as GNC, Vitamin Shoppe, Vitamin World, Europa Sports Wholesalers, Bodybuilding.com, and other retailers, and international markets will be shipped as product is made available. Initial response to both Pre-Gro™ and Hyper-Gro™ has been positive. iSatori had backlogged $374,000 in orders waiting to be filled with future production runs. The Company expects to fill those product orders prior to the end of 2Q 2015.





1






Ÿ

In January 2015, iSatori signed a multi-year endorsement agreement with one of the industry’s biggest influencers, CT Fletcher. With his nearly 2-million followers in various social media outlets, CT is known as the “master of motivation” as he accepts no excuses for not putting in the hard work to transform the body, which is a shared core value with iSatori. The Company expects this partnership to increase brand awareness and consumption of iSatori products through his wide reach and influence in Social Media. CT Fletcher will make a series of special retail and tradeshow appearances throughout the year on behalf of iSatori, and the Company is excited about the new endorsement deal which should yield dividends for the brand’s equity over time.


Ÿ

In January 2015, iSatori partnered in distribution with Sportika Export (based in Connecticut), the largest U.S. dietary supplement exporter in the world. Led by industry veterans Richard White and Barry Griffing, with their expertise in export of sports supplements and wide distribution into over 130+ countries, the Company expects to gain new international distribution in the coming year through this new, exciting channel.


Ÿ

In January 2015, the Company officially “cut the ribbon” on its 17,426-square-foot warehouse and distribution center, located in Denver, Colorado. The facility is occupied under a four-year lease and will allow the Company to house all its finished goods under one facility. New machinery also allows the Company to bundle and package promotions, internally, and thereby reduce incurred expenses normally paid for these services. The new warehouse and distribution center is expected to be accretive to the company by removing outside warehousing cost and reducing long-distance and intermittent freight expenses. In conjunction with the move, a new freight agreement with a major carrier was executed to add additional cost savings to the in-direct COGS. The Company believes the full implementation of the warehouse and distribution center will increase efficiencies in fulfillment, reduce overall transit and freight costs, and improve the customer experience.


Ÿ

In February 2015, the Company shipped the opening orders of its Energize 28-count tablet to CVS Health drugstores for national distribution. The Company also received initial purchase orders from Rite-Aid drugstores for their Energize product in February, which would expand distribution in Rite-Aid from partial to full national distribution. These customer acquisitions will increase iSatori’s retail footprint by adding over 11,000+ retail stores to its domestic distribution—increasing the Company’s ACV (all commodity volume, a measure of maximum retail distribution volume) from 18.6% to 34.1%, which includes such current retail distribution as Walmart, Walgreens, Super Value, Meijer, and other food, drug and mass retailers.


Ÿ

On April 3, 2015, Seth Yakatan was named Interim Chief Financial Officer. He currently serves as a member of the Company's Board of Directors, having joined the Board in 2014, and also serves as Vice President of Business Development for Invion, Ltd. The Company also promoted Andrea Clem to serve as Executive Vice President, Finance and Corporate Controller. Michael Wilemon, who served as the Company’s Chief Financial Officer, retired from the Company.




2






iSatori, Inc.

Condensed Balance Sheets

(Unaudited)


 

March 31,

 

December 31,

ASSETS

2015

 

2014

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

513,202 

 

$

738,725 

Accounts receivable trade

 

1,970,061 

 

 

925,506 

Note receivables - current portion

 

26,289 

 

 

28,939 

Inventories

 

2,104,615 

 

 

2,483,602 

Assets held for sale

 

28,744 

 

 

34,979 

Prepaid expenses

 

308,234 

 

 

217,668 

Total current assets

 

4,951,145 

 

 

4,429,419 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

Leasehold improvements

 

11,485 

 

 

11,485 

Furniture and fixtures

 

184,966 

 

 

128,902 

Office equipment

 

94,179 

 

 

57,408 

Computer equipment

 

332,171 

 

 

332,171 

Dies and cylinders

 

54,567 

 

 

43,942 

Less accumulated depreciation

 

(445,118)

 

 

(425,238)

 

 

 

 

 

 

Net property and equipment

 

232,250 

 

 

148,670 

 

 

 

 

 

 

Note receivable – net of current portion

 

52,695 

 

 

52,695 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

Deferred tax asset, net

 

57,314 

 

 

57,314 

Deposits and other assets

 

39,502 

 

 

45,207 

Total other assets

 

96,816 

 

 

102,521 

Total assets

$

5,332,906 

 

$

4,733,305 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Trade accounts payable

$

1,600,232 

 

$

819,918 

Accrued expenses

 

253,655 

 

 

253,208 

Deferred revenues

 

 

 

191,127 

Deferred tax liability, net

 

57,314 

 

 

57,314 

Line of credit

 

1,500,000 

 

 

1,620,519 

Notes payable

 

50,169 

 

 

15,708 

Total current liabilities

 

3,461,370 

 

 

2,957,794 

 

 

 

 

 

 

Long-term liabilities

 

 

 

 

 

Derivative liability

 

 

 

152,849 

 

 

 

 

 

 

Commitments and contingencies (Notes 1,2,5, and 6)

 

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

Convertible preferred stock, $0.01 par value, 750,000 shares authorized; 22,500 shares issued and outstanding ($450,000 of liquidation value)

 

225 

 

 

225 

Common stock, $0.01 par value, 56,250,000 shares authorized; 13,373,791 shares issued and outstanding

 

133,738 

 

 

129,093 

Additional paid-in capital

 

5,014,081 

 

 

4,796,241 

Accumulated deficit

 

(3,276,508)

 

 

(3,302,897)

Total stockholders’ equity

 

1,871,536 

 

 

1,622,662 

Total liabilities and stockholders' equity

$

5,332,906 

 

$

4,733,305 





3






iSatori, Inc.

Condensed Statement of Operations

(Unaudited)


 

For the Months Ended

 

March 31

 

2015

 

2014

Revenues:

 

 

 

 

 

Product revenue (Net of returns and discounts)

$

3,398,440 

 

$

3,219,244 

Royalty revenue

 

19,218 

 

 

32,627 

Other revenue

 

11,165 

 

 

9,396 

Total revenue

 

3,428,823 

 

 

3,261,267 

 

 

 

 

 

 

Cost of sales

 

1,709,547 

 

 

1,243,797 

Gross profit

 

1,719,276 

 

 

2,017,470 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

Selling and marketing

 

625,445 

 

 

782,687 

Salaries and labor related expenses

 

619,254 

 

 

647,413 

Administration

 

325,375 

 

 

213,978 

Depreciation and amortization

 

23,084 

 

 

19,129 

Total operating expenses

 

1,593,158 

 

 

1,663,207 

 

 

 

 

 

 

Income from operations

 

126,118 

 

 

354,263 

 

 

 

 

 

 

Other income (expense)

 

(68,223)

 

 

30,199 

Financing expense

 

(12,361)

 

 

(21,353)

Interest expense

 

(16,215)

 

 

(11,048)

 

 

 

 

 

 

Income before income taxes

 

29,319 

 

 

352,061 

 

 

 

 

 

 

Income tax expense

 

(2,930)

 

 

(15,823)

 

 

 

 

 

 

Net Income

$

26,389 

 

$

336,238 

 

 

 

 

 

 

Net income per common share  

 

 

 

 

 

Basic

$

 

$

0.03 

Diluted

$

 

$

0.02 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

Basic

 

13,004,532 

 

 

12,879,651 

Diluted

 

13,213,246 

 

 

14,546,736 






4






About iSatori, Inc.


iSatori is a consumer products firm that develops and sells scientifically engineered nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at www.isatori.com.


Forward-Looking Statements


Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "potential," and similar terms and phrases to identify forward-looking statements in this press release. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. Please see our Risk Factor disclosures included in our Registration Statement on Form S-1, as amended, initially filed with the Securities and Exchange Commission on April 30, 2013, and in subsequent filings with the Securities and Exchange Commission. All future written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the previous statements. The forward-looking statements herein speak as of the date of this press release. We undertake no obligation to update any information contained herein or to publicly release the results of any revisions to any forward-looking statements that may be made to reflect events or circumstances that occur, or that we become aware of, after the date of this press release.



Contacts

Self & Associates

Trudy M. Self

Investor Relations

909.336.5685

TMSelf@aol.com




5